Outcomes associated with hypogonadism in men with chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 11, Issue 4, 2004, Pages 342-347

  Palmer, Biff F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Department of Internal Medicine   (United States)

Author keywords

Androgens; anemia; decreased bone mass; hypogonadism; malnutrition; sexual dysfunction

Indexed keywords

ANDROGEN; TESTOSTERONE;

ANEMIA; ARTICLE; BONE MINERAL; BONE MINERALIZATION; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MALNUTRITION; MUSCLE MASS; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SUBSTITUTION THERAPY; TREATMENT OUTCOME; UREMIA;

CHRONIC DISEASE; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMPOTENCE; KIDNEY DISEASES; MALE;

EID: 5444266809     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2004.07.008     Document Type: Article

References (28)

1. S.R. Holdsworth, D.M. de Kretser, R.C. Atkins A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function Clin Nephrol 10 1978 146 150
2. W.L. Diemont, P.A. Vruggink, E.J. Meuleman Sexual dysfunction after kidney replacement therapy Am J Kidney Dis 35 2000 845 851
3. A.R. Prem, S.V. Punekar, M. Kalpana Male reproductive function in uraemia Efficacy of haemodialysis and kidney transplantation Brit J Urol 78 1996 635 638
4. C.P. De Vries, L.J.G. Gooren, P.L. Oe Haemodialysis and testicular function Int J Andrology 7 1984 97 103
5. D. Levitan, S.A. Moser, D.A. Goldstein Disturbances in the hypothalamic-pituitary-gonadal axis in male patients with acute kidney failure Am J Nephrol 4 1984 99 106
6. V.S. Lim, V.S. Fang Restoration of plasma testosterone levels in uremic men with clomiphene citrate J Clin Endocrinol Metab 43 1976 1370 1377
7. M. Stewart-Bentley, D. Gans, R. Horton Regulation of gonadal function in uremia Metabolism 23 1974 1065 1072
8. F. Schaefer, J.D. Veldhuis, W.R. Robertson, D. Dunger Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic kidney failure Kidney Int 45 1994 1465 1476
9. W. Ayub, S. Fletcher End-stage kidney disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant 15 2000 1525 1528
10. I. Phocas, A. Sarandakou, D. Rizos Serum α-immunoreactive inhibitin in males with kidney failure, under haemodialysis and after successful kidney transplantation Andrologia 27 1995 253 258
11. S.E. Rosas, M. Joffe, E. Franklin Prevalence and determinants of erectile dysfunction in hemodialysis patients Kidney Int 59 2001 2259 2266
12. S. Turk, G. Karalezli, H.Z. Tonbul Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis Nephrol Dial Transplant 16 2001 1818 1822
13. C.H. Barton, M.K. Mirahmadi, N.D. Vaziri Effects of long-term testosterone administration on pituitary-testicular axis in end-stage kidney failure Nephron 31 1982 61 64
14. A. van Coevorden, J.C. Stolear, M. Dhaene Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients Clin Nephrol 26 1986 48 54
15. I.G. Lawrence, D.E. Price, T.A. Howlett Correcting impotence in the male dialysis patient Experience with testosterone replacement and vacuum tumescence therapy Am J Kidney Dis 31 1998 313 319
16. M. Rix, H. Andreassen, P. Eskildsen Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure Kidney Int 56 1999 1084 1093
17. M. Bianchi, G. Colantonio, A. Montesano Bone mass status in different degrees of chronic renal failure Bone 13 1992 225 228
18. M. Taal, T. Masud, D. Green Risk factors for reduced bone density in haemodialysis patients Nephrol Dial Transplant 14 1999 1922 1928
19. M. Stein, D. Packham, P. Ebeling Prevalence and risk factors for osteopenia in dialysis patients Am J Kidney Dis 28 1996 515 522
20. C. Stehman-Breen, D. Sherrard, A. Walker Racial differences in bone mineral density and bone loss among end-stage renal disease patients Am J Kidney Dis 33 1999 941 946
21. J. Kopple Effect of nutrition on morbidity and mortality in maintenance dialysis patients Am J Kidney Dis 24 1994 1002 1009
22. K. Johansen, K. Mulligan, M. Schambelan Anabolic effects of nandrolone decanoate in patients receiving dialysis A randomized controlled trial JAMA 281 1999 1275 1281
23. A. Singh, K. Norris, N. Modi Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men J Clin Endocrinol Metab 86 2001 2437 2445
24. E. Hendler, J. Goffinet, S. Ross Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis N Engl J Med 291 1974 1046 1051
25. M. Neff, J. Goldberg, R. Slifkin A comparison of androgens for anemia in patients on hemodialysis N Engl J Med 304 1981 871 875
26. C. Johnson Use of androgens in patients with renal failure Semin Dial 13 2000 36 39
27. J. Teruel, R. Marcen, J. Navarro Evolution of serum erythropoietin after androgen administration to hemodialysis patients A prospective study Nephron 70 1995 282 286
28. W. Gaughan, K. Liss, S. Dunn A six month study of low dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients Am J Kidney Dis 30 1997 495 500